134 related articles for article (PubMed ID: 17416313)
1. Assessing hERG channel inhibition using PatchXpress.
Ly JQ; Shyy G; Misner DL
Clin Lab Med; 2007 Mar; 27(1):201-8. PubMed ID: 17416313
[TBL] [Abstract][Full Text] [Related]
2. Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp.
Dubin AE; Nasser N; Rohrbacher J; Hermans AN; Marrannes R; Grantham C; Van Rossem K; Cik M; Chaplan SR; Gallacher D; Xu J; Guia A; Byrne NG; Mathes C
J Biomol Screen; 2005 Mar; 10(2):168-81. PubMed ID: 15799960
[TBL] [Abstract][Full Text] [Related]
3. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
4. Effect of compound plate composition on measurement of hERG current IC(50) using PatchXpress.
Mo ZL; Faxel T; Yang YS; Gallavan R; Messing D; Bahinski A
J Pharmacol Toxicol Methods; 2009; 60(1):39-44. PubMed ID: 19442753
[TBL] [Abstract][Full Text] [Related]
5. IonFlux: a microfluidic patch clamp system evaluated with human Ether-à-go-go related gene channel physiology and pharmacology.
Golden AP; Li N; Chen Q; Lee T; Nevill T; Cao X; Johnson J; Erdemli G; Ionescu-Zanetti C; Urban L; Holmqvist M
Assay Drug Dev Technol; 2011 Dec; 9(6):608-19. PubMed ID: 21561375
[TBL] [Abstract][Full Text] [Related]
6. Automated voltage-clamp technique.
Ghetti A; Guia A; Xu J
Methods Mol Biol; 2007; 403():59-69. PubMed ID: 18827987
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HERG channels by the local anaesthetic articaine.
Siebrands CC; Friederich P
Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
[TBL] [Abstract][Full Text] [Related]
9. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
Guo L; Guthrie H
J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
[TBL] [Abstract][Full Text] [Related]
10. Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride.
Zeng H; Penniman JR; Kinose F; Kim D; Trepakova ES; Malik MG; Dech SJ; Balasubramanian B; Salata JJ
Assay Drug Dev Technol; 2008 Apr; 6(2):235-41. PubMed ID: 18471077
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp.
Haraguchi Y; Ohtsuki A; Oka T; Shimizu T
BMC Pharmacol Toxicol; 2015 Dec; 16():39. PubMed ID: 26671227
[TBL] [Abstract][Full Text] [Related]
12. Introduction of a modular automated voltage-clamp platform and its correlation with manual human Ether-à-go-go related gene voltage-clamp data.
Scheel O; Himmel H; Rascher-Eggstein G; Knott T
Assay Drug Dev Technol; 2011 Dec; 9(6):600-7. PubMed ID: 21675869
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
Sorota S; Zhang XS; Margulis M; Tucker K; Priestley T
Assay Drug Dev Technol; 2005 Feb; 3(1):47-57. PubMed ID: 15798395
[TBL] [Abstract][Full Text] [Related]
14. Halide ion effects on human Ether-à-go-go related gene potassium channel properties.
Zeng H; Balasubramanian B; Penniman JR; Kinose F; Salata JJ; Lagrutta A
Assay Drug Dev Technol; 2013; 11(9-10):544-50. PubMed ID: 24147984
[TBL] [Abstract][Full Text] [Related]
15. Reduction of hERG potassium currents by hyperosmolar solutions.
Yabuuchi F; Beckmann R; Wettwer E; Hegele-Hartung C; Heubach JF
Eur J Pharmacol; 2007 Jul; 566(1-3):222-5. PubMed ID: 17477915
[TBL] [Abstract][Full Text] [Related]
16. Application of PatchXpress planar patch clamp technology to the screening of new drug candidates for cardiac KCNQ1/KCNE1 (I Ks) activity.
Trepakova ES; Malik MG; Imredy JP; Penniman JR; Dech SJ; Salata JJ
Assay Drug Dev Technol; 2007 Oct; 5(5):617-27. PubMed ID: 17939752
[TBL] [Abstract][Full Text] [Related]
17. Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-à-go-go-related gene channels.
Perrin MJ; Kuchel PW; Campbell TJ; Vandenberg JI
Mol Pharmacol; 2008 Nov; 74(5):1443-52. PubMed ID: 18701618
[TBL] [Abstract][Full Text] [Related]
18. Analogs of MK-499 are differentially affected by a mutation in the S6 domain of the hERG K+ channel.
Karczewski J; Wang J; Kane SA; Kiss L; Koblan KS; Culberson JC; Spencer RH
Biochem Pharmacol; 2009 May; 77(10):1602-11. PubMed ID: 19426697
[TBL] [Abstract][Full Text] [Related]
19. Both EGFR kinase and Src-related tyrosine kinases regulate human ether-à-go-go-related gene potassium channels.
Zhang DY; Wang Y; Lau CP; Tse HF; Li GR
Cell Signal; 2008 Oct; 20(10):1815-21. PubMed ID: 18617000
[TBL] [Abstract][Full Text] [Related]
20. [Effect of sophocarpine on HERG K+ channels].
Qi ZP; Shi SS; Zhao XL; Zhao WX; Bai YL; Lü YJ; Li BX; Yang BF
Yao Xue Xue Bao; 2008 Jan; 43(1):44-9. PubMed ID: 18357730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]